← Browse by Condition
Medical Condition

acute myeloid leukemia refractory

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1
NCT05190471 Phase 1
Recruiting

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

Enrollment
48 pts
Location
United States
Sponsor
Bio-Path Holdings, Inc.
View Trial →
NCT05546580 Phase 1
Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
View Trial →
NCT06297941 Phase 1
Recruiting

Study of REM-422 in Patients With AML or Higher Risk MDS

Enrollment
100 pts
Location
United States, Franc...
Sponsor
Remix Therapeutics
View Trial →